定期健康診断の世界市場レポート 2025年

定期健康診断市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.4%で777億6,000万米ドルに成長します。予測期間の成長は、個別化医療の採用拡大、慢性疾患管理への注目の高まり、新興市場におけるヘルスケアアクセスの拡大、ヘルスケア支出の増加、予防医療プログラムへの官民投資の拡大などに起因しています。予測期間における主な動向としては、診断精度向上のための人工知能の統合、遠隔医療プラットフォームによる健康診断サービスの拡大、公衆衛生イニシアティブによる予防医療への注目の高まり、モバイルヘルスアプリやデジタルヘルスプラットフォームによる患者エンゲージメントの強化、高度なバイオマーカーに基づくスクリーニング技術の開発などが挙げられます。

予防ヘルスケアに対する意識の高まりは、将来的にルーチン検診市場を押し上げると予想されます。予防ヘルスケアには、早期発見、ライフスタイルの変化、積極的な介入を通じて病気や健康状態を予防することを目的とした実践や対策が含まれます。予防ヘルスケアに対する認識が高まっているのは、疾病の早期発見、健康結果の改善、コスト削減といった利点があるためであり、その原動力となっているのは公衆教育の強化と医療の進歩です。定期的な健康診断は、潜在的な健康問題を早期に発見し、タイムリーな介入を可能にし、重篤な疾患のリスクを低減することによって、予防ヘルスケアを支えています。例えば、国民保健サービス（NHS）は2023年5月、2023年3月に2,302,400件の診断検査が実施され、2022年3月と比較して223,100件増加したと報告しました。2023年3月末までに、主要な診断検査を待つ患者数は1,628,300人に上り、2022年3月から59,400人増加しました。このことは、予防ヘルスケアに対する意識の高まりが、定期健康診断市場の成長を促進していることを示しています。

定期健康診断市場の主要企業は、競争優位性を獲得するために、肺がんスクリーニング検査などの先進ソリューションの開発に注力しています。これらの検査は、リスクの高い人の肺がんを、症状が現れる前であっても早期に発見するように設計されています。例えば、2023年10月、米国を拠点とする診断技術企業であるDELFI Diagnostics, Inc.は、肺がん検診の改善を目的とした革新的な血液検査であるFirstLook Lung検査を開始しました。FirstLook Lungは、血液検体から採取した無細胞DNA（cfDNA）のパターンをフラグメントオミクスを用いて解析し、高度な機械学習を用いてがんパターンと非がんパターンを区別します。99.7％の陰性適中率（NPV）を誇るこの検査は、肺がんの可能性を正確に特定すると同時に、不必要な低線量CT（LDCT）スキャンの必要性を低減します。FirstLook Lungは、日常的な血液検査に統合され、特に十分なサービスを受けていない人々の検診率を向上させる。また、スケーラブルな全ゲノム機械学習プラットフォームを特徴としており、他のがんや治療モニタリングに世界的に拡大する可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界定期健康診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の定期健康診断市場：成長率分析
• 世界の定期健康診断市場の実績：規模と成長, 2019-2024
• 世界の定期健康診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界定期健康診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の定期健康診断市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血糖値検査
• 腎機能検査
• 骨プロファイル検査
• 電解質検査
• 肝機能検査
• 脂質プロファイル検査
• その他のテストの種類
• 世界の定期健康診断市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血
• 尿
• 血清
• 唾液
• その他のサンプルタイプ
• 世界の定期健康診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量的ポリメラーゼ連鎖反応（QPCR）
• 定量的蛍光in situハイブリダイゼーション（Q-FISH）
• 免疫測定
• 医療画像
• 単一テロメア長解析（STELA）
• その他のテクノロジー
• 世界の定期健康診断市場サンプル採取場所別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 住宅
• 診断検査室
• オフィス
• その他のサンプル収集場所
• 世界の定期健康診断市場血糖値検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 空腹時血糖値検査
• HbA1c検査
• 持続血糖モニタリング
• 世界の定期健康診断市場腎機能検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清クレアチニン検査
• 血中尿素窒素（BUN）検査
• 尿検査
• 世界の定期健康診断市場骨プロファイル検査のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清カルシウム検査
• リン酸テスト
• 骨密度（BMD）検査
• 世界の定期健康診断市場電解質検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清ナトリウム検査
• 血清カリウム検査
• 血清塩化物検査
• 世界の定期健康診断市場肝機能検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アラニンアミノトランスフェラーゼ（ALT）検査
• アスパラギン酸アミノトランスフェラーゼ（AST）検査
• ビリルビン検査
• 世界の定期健康診断市場脂質プロファイル検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 総コレステロール検査
• 低密度リポタンパク質（LDL）検査
• 高密度リポタンパク質（HDL）検査
• 世界の定期健康診断市場、その他のテストタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺機能検査
• 全血球数（CBC）
• 前立腺特異抗原（PSA）検査

第7章 地域別・国別分析

• 世界の定期健康診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の定期健康診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 定期健康診断市場：競合情勢
• 定期健康診断市場：企業プロファイル
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eurofins Scientific SE
• Agilent Technologies Inc.
• Sonic Healthcare Limited
• Hologic Inc.
• Illumina Inc.
• SYNLAB International GmbH
• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• RadNet Inc.
• Opko Health Inc.
• UNILABS
• Amedes Holding GmbH
• Natera Inc.
• Grail Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 定期健康診断市場2029：新たな機会を提供する国
• 定期健康診断市場2029：新たな機会を提供するセグメント
• 定期健康診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Routine health screening involves regular medical tests and check-ups designed to detect potential health issues before symptoms arise. These screenings are essential for monitoring overall health, identifying risk factors, and preventing serious conditions such as heart disease, diabetes, or cancer. Recommendations for screenings are typically based on factors such as age, gender, and health history, and they play a crucial role in maintaining long-term health and well-being.

The main types of routine health screenings include blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, and others. A blood glucose test measures the level of glucose (sugar) in the blood to detect or manage diabetes. Samples for these tests can be obtained from blood, urine, serum, saliva, and other sources. Technologies used in these screenings include quantitative polymerase chain reaction (QPCR), quantitative fluorescence in situ hybridization (Q-FISH), immunoassays, medical imaging, single telomere length analysis (STELA), and others. Sample collection sites for these tests may include hospitals, homes, diagnostic laboratories, offices, and other locations.

The routine health screening market research report is one of a series of new reports from The Business Research Company that provides routine health screening market statistics, including routine health screening industry global market size, regional shares, competitors with a routine health screening market share, detailed routine health screening market segments, market trends and opportunities, and any further data you may need to thrive in the routine health screening industry. This routine health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The routine health screening market size has grown strongly in recent years. It will grow from $54.28 billion in 2024 to $58.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the rising prevalence of chronic diseases, growing government initiatives for early disease detection, the aging global population, and the expansion of healthcare infrastructure.

The routine health screening market size is expected to see strong growth in the next few years. It will grow to $77.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to the growing adoption of personalized medicine, increasing focus on chronic disease management, expansion of healthcare access in emerging markets, rising healthcare spending, and greater public and private investment in preventive health programs. Major trends in the forecast period include the integration of artificial intelligence for improved diagnostic accuracy, expansion of health screening services through telemedicine platforms, heightened focus on preventive care driven by public health initiatives, enhanced patient engagement through mobile health apps and digital health platforms, and the development of advanced biomarker-based screening technologies.

The growing awareness of preventive healthcare is expected to boost the routine health screenings market in the future. Preventive healthcare involves practices and measures aimed at preventing diseases and health conditions through early detection, lifestyle changes, and proactive interventions. Increased awareness of preventive healthcare is due to its advantages in early disease detection, improved health outcomes, and cost savings, driven by enhanced public education and medical advancements. Routine health screenings support preventive healthcare by identifying potential health issues early, enabling timely interventions, and reducing the risk of severe diseases. For example, the National Health Service (NHS) reported in May 2023 that 2,302,400 diagnostic tests were conducted in March 2023, an increase of 223,100 tests compared to March 2022. By the end of March 2023, the number of patients waiting for a key diagnostic test had risen to 1,628,300, an increase of 59,400 from March 2022. This indicates that the rising awareness of preventive healthcare is driving growth in the routine health screenings market.

Leading companies in the routine health screenings market are focusing on developing advanced solutions, such as lung cancer screening tests, to gain a competitive advantage. These tests are designed to detect lung cancer early in individuals at high risk, even before symptoms appear. For instance, in October 2023, DELFI Diagnostics, Inc., a U.S.-based diagnostic technology company, launched the FirstLook Lung test, an innovative blood test aimed at improving lung cancer screening. FirstLook Lung uses fragmentomics to analyze patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to distinguish between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test accurately identifies potential lung cancer cases while reducing the need for unnecessary low-dose CT (LDCT) scans. FirstLook Lung is integrated into routine blood tests to improve screening rates, especially among underserved populations, and features a scalable whole-genome machine-learning platform that could potentially expand into other cancers and treatment monitoring globally.

In March 2024, Laboratory Corporation of America Holdings, a U.S.-based healthcare and diagnostics company, acquired BioReference Health from OPKO Health, Inc. for $237.5 million. This acquisition is intended to enhance Labcorp's capabilities and access in routine health screening. BioReference Health, a U.S.-based diagnostic laboratory company, offers testing services, including routine health screenings, oncology, urology, and reproductive and women's health tests.

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the routine health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The routine health screening market consists of revenues earned by entities by providing services such as health assessments, screening procedures, consultations, telehealth screenings, and corporate wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The routine health screening also includes sales of diagnostic test kits, medical devices, wearable health devices, and laboratory testing supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Routine Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on routine health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for routine health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The routine health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Blood Glucose Test; Kidney Function Test; Bone Profile Test; Electrolyte Test; Liver Function Test; Lipid Profile Test; Other Test Types
• 2) By Sample Type: Blood; Urine; Serum; Saliva; Other Sample Types
• 3) By Technology: Quantitative Polymerase Chain Reaction (QPCR); Quantitative Fluorescence In Situ Hybridization (Q-FISH); Immunoassays; Medical Imaging; Single Telomere Length Analysis (STELA); Other Technologies
• 4) By Sample Collection Sites: Hospitals; Homes; Diagnostic Laboratories; Offices; Other Sample Collection Sites
• Subsegments:
• 1) By Blood Glucose Test: Fasting Blood Glucose Test; HbA1c Test; Continuous Glucose Monitoring
• 2) By Kidney Function Test: Serum Creatinine Test; Blood Urea Nitrogen (BUN) Test; Urinalysis
• 3) By Bone Profile Test: Serum Calcium Test; Phosphate Test; Bone Mineral Density (BMD) Test
• 4) By Electrolyte Test: Serum Sodium Test; Serum Potassium Test; Serum Chloride Test
• 5) By Liver Function Test: Alanine Aminotransferase (ALT) Test; Aspartate Aminotransferase (AST) Test; Bilirubin Test
• 6) By Lipid Profile Test: Total Cholesterol Test; Low-Density Lipoprotein (LDL) Test; High-Density Lipoprotein (HDL) Test
• 7) By Other Test Types: Thyroid Function Test; Complete Blood Count (CBC); Prostate-Specific Antigen (PSA) Test
• Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Siemens Healthineers; Laboratory Corporation; Quest Diagnostics Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Routine Health Screening Market Characteristics

3. Routine Health Screening Market Trends And Strategies

4. Routine Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Routine Health Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Routine Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Routine Health Screening Market Growth Rate Analysis
• 5.4. Global Routine Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Routine Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Routine Health Screening Total Addressable Market (TAM)

6. Routine Health Screening Market Segmentation

• 6.1. Global Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Glucose Test
• Kidney Function Test
• Bone Profile Test
• Electrolyte Test
• Liver Function Test
• Lipid Profile Test
• Other Test Types
• 6.2. Global Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Urine
• Serum
• Saliva
• Other Sample Types
• 6.3. Global Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative Polymerase Chain Reaction (QPCR)
• Quantitative Fluorescence In Situ Hybridization (Q-FISH)
• Immunoassays
• Medical Imaging
• Single Telomere Length Analysis (STELA)
• Other Technologies
• 6.4. Global Routine Health Screening Market, Segmentation By Sample Collection Sites, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homes
• Diagnostic Laboratories
• Offices
• Other Sample Collection Sites
• 6.5. Global Routine Health Screening Market, Sub-Segmentation Of Blood Glucose Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fasting Blood Glucose Test
• HbA1c Test
• Continuous Glucose Monitoring
• 6.6. Global Routine Health Screening Market, Sub-Segmentation Of Kidney Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Creatinine Test
• Blood Urea Nitrogen (BUN) Test
• Urinalysis
• 6.7. Global Routine Health Screening Market, Sub-Segmentation Of Bone Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Calcium Test
• Phosphate Test
• Bone Mineral Density (BMD) Test
• 6.8. Global Routine Health Screening Market, Sub-Segmentation Of Electrolyte Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Sodium Test
• Serum Potassium Test
• Serum Chloride Test
• 6.9. Global Routine Health Screening Market, Sub-Segmentation Of Liver Function Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alanine Aminotransferase (ALT) Test
• Aspartate Aminotransferase (AST) Test
• Bilirubin Test
• 6.10. Global Routine Health Screening Market, Sub-Segmentation Of Lipid Profile Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Cholesterol Test
• Low-Density Lipoprotein (LDL) Test
• High-Density Lipoprotein (HDL) Test
• 6.11. Global Routine Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Function Test
• Complete Blood Count (CBC)
• Prostate-Specific Antigen (PSA) Test

7. Routine Health Screening Market Regional And Country Analysis

• 7.1. Global Routine Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Routine Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Routine Health Screening Market

• 8.1. Asia-Pacific Routine Health Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Routine Health Screening Market

• 9.1. China Routine Health Screening Market Overview
• 9.2. China Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Routine Health Screening Market

• 10.1. India Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Routine Health Screening Market

• 11.1. Japan Routine Health Screening Market Overview
• 11.2. Japan Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Routine Health Screening Market

• 12.1. Australia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Routine Health Screening Market

• 13.1. Indonesia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Routine Health Screening Market

• 14.1. South Korea Routine Health Screening Market Overview
• 14.2. South Korea Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Routine Health Screening Market

• 15.1. Western Europe Routine Health Screening Market Overview
• 15.2. Western Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Routine Health Screening Market

• 16.1. UK Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Routine Health Screening Market

• 17.1. Germany Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Routine Health Screening Market

• 18.1. France Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Routine Health Screening Market

• 19.1. Italy Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Routine Health Screening Market

• 20.1. Spain Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Routine Health Screening Market

• 21.1. Eastern Europe Routine Health Screening Market Overview
• 21.2. Eastern Europe Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Routine Health Screening Market

• 22.1. Russia Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Routine Health Screening Market

• 23.1. North America Routine Health Screening Market Overview
• 23.2. North America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Routine Health Screening Market

• 24.1. USA Routine Health Screening Market Overview
• 24.2. USA Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Routine Health Screening Market

• 25.1. Canada Routine Health Screening Market Overview
• 25.2. Canada Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Routine Health Screening Market

• 26.1. South America Routine Health Screening Market Overview
• 26.2. South America Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Routine Health Screening Market

• 27.1. Brazil Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Routine Health Screening Market

• 28.1. Middle East Routine Health Screening Market Overview
• 28.2. Middle East Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Routine Health Screening Market

• 29.1. Africa Routine Health Screening Market Overview
• 29.2. Africa Routine Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Routine Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Routine Health Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Routine Health Screening Market Competitive Landscape And Company Profiles

• 30.1. Routine Health Screening Market Competitive Landscape
• 30.2. Routine Health Screening Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Routine Health Screening Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. Sonic Healthcare Limited
• 31.4. Hologic Inc.
• 31.5. Illumina Inc.
• 31.6. SYNLAB International GmbH
• 31.7. Sysmex Corporation
• 31.8. QIAGEN N.V.
• 31.9. Exact Sciences Corporation
• 31.10. RadNet Inc.
• 31.11. Opko Health Inc.
• 31.12. UNILABS
• 31.13. Amedes Holding GmbH
• 31.14. Natera Inc.
• 31.15. Grail Inc.

32. Global Routine Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Routine Health Screening Market

34. Recent Developments In The Routine Health Screening Market

35. Routine Health Screening Market High Potential Countries, Segments and Strategies

• 35.1 Routine Health Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Routine Health Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Routine Health Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33548_Routine_Health_Screening_GMR_2025